Carregant...
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
Pegylated liposomal doxorubicin (PLD) has become a major component in the routine management of epithelial ovarian cancer. The drug is frequently employed as a single agent in the platinum-resistant setting, and recently reported data reveal the superiority of the combination of PLD plus carboplatin...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3139482/ https://ncbi.nlm.nih.gov/pubmed/21792330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMR.S15558 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|